Scotland’s Thriving Life Sciences Sector Defies PredictionsSteve Jarvis2024-03-21T15:55:33+00:00March 21st, 2024|BioCity Glasgow, Edinburgh Technopole, Investment, News|
Pioneer Group Leads $2.34m Investment In Neobe Therapeutics’ Cancer Therapy InnovationSteve Jarvis2024-11-28T14:25:26+00:00February 29th, 2024|Investment, News|
BioCity Glasgow: BioAscent Invests In New State-Of-The-Art Protein Production FacilitySteve Jarvis2024-11-28T14:25:44+00:00February 23rd, 2024|BioCity Glasgow, Investment, News|
IsomAb Closes £7.5m Financing To Drive New Diabetic TreatmentSteve Jarvis2024-11-28T14:26:00+00:00February 21st, 2024|BioCity Nottingham, Investment, News|
MIP Discovery Raises £7m To Advance CommercialisationSteve Jarvis2024-11-28T14:26:13+00:00February 21st, 2024|Colworth Park, Investment, News|
Ireland Accelerator Programme Winners NeuroBell Secure £1.8m Funding RoundSteve Jarvis2024-01-31T12:30:00+00:00January 31st, 2024|Accelerator, News|
Pioneer Group And CPI Collaborate On ‘Golden Ticket’ Programme For Planetary Health InnovationsSteve Jarvis2024-11-28T14:27:13+00:00January 30th, 2024|Accelerator, News, Wilton Centre|
Pioneer Group And Innovate UK Join Forces To Accelerate The Development Of Life Sciences Companies Steve Jarvis2024-11-28T14:28:31+00:00December 11th, 2023|Investment, News|
Pioneer Life Sciences Fund Invests In First Of Its Kind At-Home Fertility Care Company Béa Fertility Steve Jarvis2024-11-28T14:28:56+00:00November 22nd, 2023|Investment, News|
Operational Excellence Will Be Key In A Maturing Life Sciences MarketSteve Jarvis2024-11-28T14:02:51+00:00November 21st, 2023|Article, Investment, News|
